Study: MS drugs help, but come at high cost
A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms ...
Jul 20, 2011
0
0